COVID-19 | Health Equity
COVID-19 Vaccines: One Year Later
Virtual Conversation with Nicole Lurie, MD, MSPH, Florence Momplaisir, MD, MSHP, FACP, Paul Offit, MD, and Ala Stanford, MD, moderated by Alison Buttenheim, PhD, MBA
Nearly a year after the federal emergency authorization of the first COVID-19 vaccine, we have made some progress toward ending the pandemic. However, many challenges remain—in vaccine distribution, vaccine uptake, and the emergence of new variants, including the omicron variant—that threaten the progress we’ve made. Penn LDI reconvened a panel of experts to talk about what we’ve learned about COVID-19 vaccines, what we’re still learning, and what we can potentially expect for the future.
Supported by the Charles C. Leighton, MD Memorial Lecture Fund.
U.S. Director and Strategic Advisor to the CEO, Coalition for Epidemic Preparedness Initiatives, and Former Assistant Secretary for Preparedness and Response, Department of Health and Human Services
Director, Vaccine Education Center and Professor of Pediatrics, Division of Infectious Diseases, Children’s Hospital of Philadelphia, and Maurice R. Hilleman Chair of Vaccinology, Perelman School of Medicine
Associate Professor of Family and Community Health, School of Nursing, Director of Engagement, Penn LDI, and Scientific Director, Center for Health Incentives and Behavioral Economics (CHIBE), Perelman School of Medicine
Event Access Info
Please click the link to join the webinar:
933 5676 4317
+1 301 715 8592
+1 646 558 8656
International numbers available: https://upenn.zoom.us/u/aeHp1jIbqt